Panagora Asset Management’s Biostage, Inc. Common Stock BSTG Stock Holding History

Panagora Asset Management’s Portfolio BSTG Stock Details BSTG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-211,820	Closed	-$65K	–	2434
2017 Q3	$65K	Sell	211,820 -45,635	-18%	-$18.3K	﹤0.01%	2006
2017 Q2	$106K	Buy	257,455 +226,474	+731%	+$72K	﹤0.01%	1857
2017 Q1	$11K	Hold	30,981	–	–	﹤0.01%	2260
2016 Q4	$28K	Hold	30,981	–	–	﹤0.01%	2178
2016 Q3	$33K	Buy	+30,981	New	+$33.3K	﹤0.01%	2196
2014 Q4	–	Sell	-24,468	Closed	-$198K	–	2398
2014 Q3	$198K	Sell	24,468 -12,663	-34%	-$104K	﹤0.01%	1644
2014 Q2	$388K	Buy	37,131 +14,531	+64%	+$124K	﹤0.01%	1480
2014 Q1	$205K	Buy	22,600 +530	+2%	+$3.14K	﹤0.01%	1732
2013 Q4	$105K	Buy	+22,070	New	+$103K	﹤0.01%	1845

Panagora Asset Management's BSTG Position: Q4 2017 in Review

Panagora Asset Management sold out of Biostage, Inc. Common Stock (BSTG) in Q4 2017, closing a stake of 211,820 shares — an estimated $65K sold.

Panagora Asset Management first reported a position in BSTG in Q4 2013 and held it in 9 quarters. The position peaked at $388K in Q2 2014. 0 funds tracked by Wall St. Rank hold BSTG as of Q4 2017.

Panagora Asset Management reported no remaining Biostage, Inc. Common Stock position as of Q4 2017 after selling out during the quarter.
Panagora Asset Management sold 211,820 Biostage, Inc. Common Stock shares in Q4 2017, an estimated $65K.
Panagora Asset Management first reported a position in Biostage, Inc. Common Stock in Q4 2013 and held it in 9 quarters.
Panagora Asset Management's Biostage, Inc. Common Stock position peaked at $388K in Q2 2014.
0 funds tracked by Wall St. Rank held Biostage, Inc. Common Stock as of Q4 2017.

Based on Panagora Asset Management's 13F filing for Q4 2017, filed 14 Feb 2018.